<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>c-Kit Expression is Rate-Limiting for Stem Cell Factor-Mediated Disease Progression in Adenoid Cystic Carcinoma of the Salivary Glands.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="c-Kit Expression is Rate-Limiting for Stem Cell Factor-Mediated Disease Progression in Adenoid Cystic Carcinoma of the Salivary Glands." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53cd/4225653/3c1760950d4a/gr1.jpg"/> </div> <div class="text-side"> <h1>c-Kit Expression is Rate-Limiting for Stem Cell Factor-Mediated Disease Progression in Adenoid Cystic Carcinoma of the Salivary Glands.</h1> <p>Expression of c-Kit, SCF, and P-ERK1/2 in ACC of the salivary glands. (A) H&amp;E staining. (B)–(F). Immunohistochemistry with antibodies to c-Kit (B), SCF (C and D), phospho-p44/42 ERK1/2 (E); antibody isotype control (F). SCF staining was largely in the duct-type epithelial component in the tumors (C and D; indicated by black arrows) where c-Kit was predominantly elevated (B). We observed a significant induction of ERK1/2 activity in the cells (E; black arrows). The staining intensity scales are as follows; c-Kit (B: 2-3 +), SCF (C and D: 1 +), and P-ERK1/2 (E: 2 +).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/25389449/" target="_blank">25389449</a></p><p>Type: Premalignant/Malignant, Category: Adnexal</p>
</div> </div></div></body></html>